Search Results
10
Everything
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
February 20, 2024 08:00 ET
|
NMDP
Groundbreaking Trial Seeks to Enhance Blood Cancer Treatment Efficacy and Safety.
NMDP/Be The Match® PTCy Research Levels the Field between Matched and Mismatched Hematopoietic Cell Transplantation
December 11, 2023 15:00 ET
|
Be The Match
The study shows the practice-changing potential of using mismatched unrelated donors to expand access to all patients regardless of ancestry.
Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
May 24, 2023 11:28 ET
|
Be The Match
MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the...
The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
May 17, 2023 08:12 ET
|
Be The Match
MINNEAPOLIS, May 17, 2023 (GLOBE NEWSWIRE) -- The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving...
Results of Study on Cryopreserved Hematopoietic Stem Cell Grafts By CIBMTR Published in Blood Advances
April 18, 2023 08:00 ET
|
Be The Match
MINNEAPOLIS, April 18, 2023 (GLOBE NEWSWIRE) -- CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced that the results of a multi-center observational study, around the...
National Marrow Donor Program/Be The Match Continues to Invest in Researchers of Tomorrow and Expands its Philanthropically Funded Research Programs
March 16, 2023 16:08 ET
|
Be The Match
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match® announced two recipients of its Amy Strelzer Manasevit Research Program grant for 2023. The grant...
The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists Will Gather for the 2023 Tandem Meetings
November 30, 2022 12:00 ET
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The 2023 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® will connect the international community of hematopoietic...
Dr. Owhofasa Agbedia to Receive the 2021 ASH-CIBMTR-ASTCT Career Development Award
June 22, 2022 11:00 ET
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, June 22, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American...
Incysus Therapeutics Announces Presentations at 2018 ASH and HAPLO Annual Meetings
November 28, 2018 16:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...